409 related articles for article (PubMed ID: 33183342)
1. p47
Gong P; Chen YQ; Lin AH; Zhang HB; Zhang Y; Ye RD; Yu Y
Alzheimers Res Ther; 2020 Nov; 12(1):146. PubMed ID: 33183342
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
[TBL] [Abstract][Full Text] [Related]
3. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y
J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772
[TBL] [Abstract][Full Text] [Related]
4. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
5. The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
Zhang H; Lin A; Gong P; Chen Y; Ye RD; Qian F; Zhang Y; Yu Y
J Neurosci; 2020 Sep; 40(36):6991-7007. PubMed ID: 32801154
[TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase 2 as a potential therapeutic target for protection against cognitive deficits following systemic inflammation in mice.
Huang WY; Liu KH; Lin S; Chen TY; Tseng CY; Chen HY; Wu HM; Hsu KS
Brain Behav Immun; 2020 Feb; 84():242-252. PubMed ID: 31841660
[TBL] [Abstract][Full Text] [Related]
7. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
8. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
[TBL] [Abstract][Full Text] [Related]
9. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
[TBL] [Abstract][Full Text] [Related]
10. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
Zhang ZX; Zhao RP; Wang DS; Wang AN
Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
[TBL] [Abstract][Full Text] [Related]
11. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
Cells; 2021 May; 10(5):. PubMed ID: 34064687
[TBL] [Abstract][Full Text] [Related]
12. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
[TBL] [Abstract][Full Text] [Related]
13. [Puerarin alleviates cognitive impairment and tau hyperphosphorylation in APP/PS1 transgenic mice].
Mei ZR; Tan XP; Liu SZ; Huang HH
Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3285-3289. PubMed ID: 28920384
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
Chen F; Yang D; Cheng XY; Yang H; Yang XH; Liu HT; Wang R; Zheng P; Yao Y; Li J
Biol Pharm Bull; 2021 Nov; 44(11):1688-1696. PubMed ID: 34433707
[TBL] [Abstract][Full Text] [Related]
15. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
16. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
17. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
18. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
19. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
Farfara D; Sooliman M; Avrahami L; Royal TG; Amram S; Rozenstein-Tsalkovich L; Trudler D; Blanga-Kanfi S; Eldar-Finkelman H; Pahnke J; Rosenmann H; Frenkel D
J Neuroinflammation; 2023 Jul; 20(1):174. PubMed ID: 37496076
[TBL] [Abstract][Full Text] [Related]
20. Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance.
Guo XD; Sun GL; Zhou TT; Xu X; Zhu ZY; Rukachaisirikul V; Hu LH; Shen X
Acta Pharmacol Sin; 2016 Sep; 37(10):1281-1297. PubMed ID: 27569389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
